86303-22-2

Basic information

• Product Name: BIG CHAP
• Synonyms: BIG CHAP;CHAP, BIG;N,N'-BIS(3-D-GLUCON-AMIDOPROPYL)CHOLAMIDE;N,N-BIS(3-D-GLUCONAMIDOPROPYL)CHOLAMIDE;N N-BIS(3-(D-GLUCONAMIDO)-PROPYL) &;BigChap(N,N-Bis[3-D-Gluconamidopropyl]-Cholamide);(3a,5b,7a,12a)-N,N-Bis[3-(D-gluconoylamino)propyl]-3,7,12-trihydroxycholan-24-amide;N,N-Bis[3-D-gluconamidopropyl]cholamide (Ultra Pure)
• CAS NO: 86303-22-2
• Molecular Formula: C42H75N3O16
• Molecular Weight: 878.06
• EINECS: 689-123-4
• Product Categories: Detergents;detergent
• Mol File: 86303-22-2.mol
• Article Data: 0

Chemical Properties

• Melting Point: 136-145°C
• Boiling Point: 1189.1°Cat760mmHg
• Flash Point: 673°C
• Appearance: /
• Density: 1.368
• Refractive Index: 1.605
• Storage Temp.: 2-8°C
• Solubility: DMSO (Slightly), Methanol (Slightly, Heated, Sonicated), Water (Very Slightly)
• PKA: 12.15±0.20(Predicted)
• Stability: Moisture Sensitive - Hygroscopic
• CAS DataBase Reference: BIG CHAP(CAS DataBase Reference)
• NIST Chemistry Reference: BIG CHAP(86303-22-2)
• EPA Substance Registry System: BIG CHAP(86303-22-2)

Safety Data

• Hazard Codes: T
• Statements: 61-20/21-36/37/38
• Safety Statements: 53-22-36/37/39-45
• WGK Germany: 1
• F: 3-10
• Hazardous Substances Data: 86303-22-2(Hazardous Substances Data)

Usage

Description

BIG CHAP, also known as N,N-Bis[3-D-gluconaMidopropyl]cholaMide, is a unique compound with specific properties that make it valuable in various applications. Its structure and composition allow it to interact with different substances, providing benefits in a range of industries.

Uses

Used in Pharmaceutical Industry:
BIG CHAP is used as a solubilizing agent for functional opiate receptors. This application is particularly important in the development of pharmaceuticals targeting the opioid system, where solubility can be a critical factor in the effectiveness and delivery of drugs.
The versatility of BIG CHAP in enhancing the solubility of functional opiate receptors highlights its potential as a valuable tool in the pharmaceutical industry, contributing to the advancement of treatments and therapies that rely on targeting these receptors.

InChI:InChI=1/C40H71N3O16/c1-19(22-5-6-23-30-24(16-28(50)40(22,23)3)39(2)9-8-21(46)14-20(39)15-25(30)47)4-7-29(51)43(12-10-41-37(58)35(56)33(54)31(52)26(48)17-44)13-11-42-38(59)36(57)34(55)32(53)27(49)18-45/h19-28,30-36,44-50,52-57H,4-18H2,1-3H3,(H,41,58)(H,42,59)/t19-,20+,21-,22-,23+,24+,25-,26?,27?,28+,30+,31?,32?,33?,34?,35?,36?,39+,40-/m1/s1